|
🐜
|
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy
18 auth.
Y. Kang,
M. Ryu,
S. Park,
J. Kim,
J. Kim,
S. Cho,
Y. Park,
S. Park,
S. Rha,
M. Kang,
...
J. Cho,
S. Kang,
S. Roh,
B. Ryoo,
B. Nam,
Y. Jo,
K. Yoon,
S. Oh
|
5 |
2018 |
5
🐜
|
|
🐜
|
Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression
7 auth.
B. Lee,
S. Kang,
K-A Kim,
Y-J Song,
K. H. Cheong,
Hyun-Young Cha,
...
C-H Kim
|
5 |
2014 |
5
🐜
|
|
🦁
|
Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax.
14 auth.
S. Kang,
Y. Oh,
J. Han,
J. Choi,
H-Y Lim,
H. Kim,
H. Lee,
J. Jang,
J. Park,
H. Kim,
...
S. Kang,
M. Chun,
C. Kim,
H. Joo
|
2 |
2006 |
2
🦁
|
|
🦁
|
Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax.
14 auth.
S. Kang,
Y. Oh,
J. Han,
J. Choi,
H-Y Lim,
H. Kim,
H. Lee,
J. Jang,
J. Park,
H. Kim,
...
S. Kang,
M. Chun,
C. Kim,
H. Joo
|
2 |
2006 |
2
🦁
|
|
🐜
|
Risk Stratification of Symptomatic Brain Metastases By Clinical and FDG PET Parameters for the Selective Use of Prophylactic Cranial Irradiation in Patients with Extensive Disease of Small Cell Lung Cancer
8 auth.
J. Chung,
S. Kang,
H. Wu,
Y. Seo,
D. W. Kim,
K. Kang,
...
G. Cheon,
H. J. Kim
|
2 |
2019 |
2
🐜
|
|
🐜
|
P86.12 Cardiac Safety Assessment of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer
18 auth.
N. Haddish-Berhane,
B. Cho,
M. Ahn,
J.-Y. Han,
S. Kim,
K. Lee,
E. Cho,
J. Mehta,
John Xie,
S. Shreeve,
...
R. Knoblauch,
J. Freeman,
A. Roshak,
S. Jang,
H. Lee,
S. Kang,
K. Kim,
S. Oh
|
1 |
2021 |
1
🐜
|
